KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Profit After Tax: 2009-2014

Historic Profit After Tax for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$45.2 million.

  • Biocryst Pharmaceuticals' Profit After Tax fell 67.46% to -$14.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$36.6 million, marking a year-over-year increase of 6.14%. This contributed to the annual value of -$45.2 million for FY2014, which is 50.09% down from last year.
  • Biocryst Pharmaceuticals' Profit After Tax amounted to -$45.2 million in FY2014, which was down 50.09% from -$30.1 million recorded in FY2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' Profit After Tax peaked at -$30.1 million during FY2013, and registered a low of -$56.9 million during FY2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Profit After Tax averaged around -$38.1 million, with its median value being -$39.1 million (2012).
  • In the last 5 years, Biocryst Pharmaceuticals' Profit After Tax tumbled by 151.68% in 2010 and then soared by 31.37% in 2012.
  • Biocryst Pharmaceuticals' Profit After Tax (Yearly) stood at -$33.9 million in 2010, then crashed by 68.22% to -$56.9 million in 2011, then soared by 31.37% to -$39.1 million in 2012, then increased by 22.96% to -$30.1 million in 2013, then plummeted by 50.09% to -$45.2 million in 2014.